Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
MS clinical trials: what can subgroup analyses teach us?
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.
Delayed visual evoked response in optic neuritis.
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
Spotlight on teriflunomide.
Neuroprotection in a novel mouse model of multiple sclerosis.
Biogen Idec to acquire Fumapharm AG; Consolidates ownership of oral compound BG-12 being studied for multiple sclerosis
Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Cerebellar cortical demyelination in the murine cuprizone model.
Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
Firategrast: natalizumab in a pill?

Pages